Are you over 18 and want to see adult content?
More Annotations
A complete backup of https://balkanje.com/turske-serije/crna-guja-2008/
Are you over 18 and want to see adult content?
A complete backup of https://balkanje.com/latino-serije/tajna-ljubav-2011/
Are you over 18 and want to see adult content?
A complete backup of https://balkanje.com/latino-serije/znam-ko-si-2017/
Are you over 18 and want to see adult content?
A complete backup of https://balkanje.com/turske-serije/milost-2013-2014/
Are you over 18 and want to see adult content?
A complete backup of https://balkanje.com/turske-serije/elif-2014/
Are you over 18 and want to see adult content?
A complete backup of https://balkanje.com/turske-serije/mlecni-put-2009/
Are you over 18 and want to see adult content?
A complete backup of https://balkanje.com/latino-serije/sveta-djavolica/
Are you over 18 and want to see adult content?
Favourite Annotations
A complete backup of officerakuten.sharepoint.com
Are you over 18 and want to see adult content?
A complete backup of blackdogballroom.co.uk
Are you over 18 and want to see adult content?
Text
ALK - CANADA
ALK is leading the industry’s research into the role respiratory allergies play in asthma. As part of this research, we conducted the world’s largest allergy immunotherapy trial ever carried out in children to investigate the effect of a new treatment on the risk ofdeveloping asthma.
2020 PRODUCT CATALOG 6 Call Sales Support at 800-325-7354 PRE-PEN® (benzylpenicilloyl polylysine injection USP) is manufactured by AllerQuest, LLC, and distributed exclusively by ALK. PRE-PEN® (benzylpenicilloyl polylysine injection USP) is a clear, colorless, sterile solution supplied in 0.25 mL sealed glass ampules. Each ampule is sufficient to evaluate one patient by skin prick (percutaneous) test and ALK RELEASES 2020 ANNUAL REPORT ALK’s ( ALKB:DC / OMX: ALK B / AKABY / AKBLF) Board of Directors has approved the company’s 2020 annual report: ALK ended 2020 strongly, with organic growth of 16% in Q4, despite the ongoing impact of COVID. Full-year revenue and EBITDA was in line with the most recentguidance.
CONTACT US | ALK
Corporate headquarters: ALK Bøge Allé 6-8 DK-2970 Hørsholm Denmark. E-mail: reception@alk-abello.com T (+45) 4574 7576 F (+45) 4574 8690. Local offices: We have offices, production and research facilities in32 countries.
ALK PRODUCT CATALOG
ALK-Abelló A/S ∙ Bøge Allé 6 ∙ DK-2970 Hørsholm ∙ Denmark ∙ CVR no. 63717916 ∙ T +45 45 74 75 76 Privacy notice | Cookie notice | Terms of Use © 2018AFFILIATE LIST
China. ALK-Abello A/S (branch) Unit 1803, Midas Plaza, No. 1 Tai Yau Street, San Po Kong, Kowloon. Hong Kong, China. T: +852 2144 5218. F: +852 2144 5618. ALK Medical Consulting. Services Company Limited. Room 1202, Cross Region Times Building, No. 1777 North Zhongshan Road,Putuo District.
ALK - USA | A WORLD LEADER IN ALLERGY IMMUNOTHERAPY Understanding immunotherapy. Allergy immunotherapy, or AIT, treats the underlying cause of environmental allergies using a person’s own immune system. Small amounts of allergens are introduced into the body so the immune system can gradually learn to tolerate them better. It targets the specific allergy trigger that causes the immune systemVACANT POSITIONS
Auxiliar de Control BioquÃmico. 06/30/2021. Técnico para Control BioquÃmico. 06/30/2021. IT Systems Engineer – Infrastructure Services (ServiceNow) Kraków. 06/01/2021. Senior System Specialist (Senior BI Consultant) Kraków. FACHINFORMATION ZUSAMMENFASSUNG DER MERKMALE DES … 1. BEZEICHNUNG DES ARZNEIMITTELS ®GRAZAX 75.000 SQ-T - Lyophilisat zum Einnehmen 2. QUALITATIVE UND QUANTITATIVE ZUSAMMENSETZUNG Standardisierter Allergenextrakt aus Gräserpollen vom ALK | ALLERGY SOLUTIONS FOR LIFEYOUR ALLERGYOUR SOLUTIONSOUR SCIENCEOUR COMPANYSUSTAINABILITYINVESTORS Since 1923, we have consistently devised and developed major advances for the treatment of allergy. In recent years, we have invested substantially in the research and development of new, evidence-based allergy immunotherapy treatments. Read more about ALK's history.ALK - CANADA
ALK is leading the industry’s research into the role respiratory allergies play in asthma. As part of this research, we conducted the world’s largest allergy immunotherapy trial ever carried out in children to investigate the effect of a new treatment on the risk ofdeveloping asthma.
2020 PRODUCT CATALOG 6 Call Sales Support at 800-325-7354 PRE-PEN® (benzylpenicilloyl polylysine injection USP) is manufactured by AllerQuest, LLC, and distributed exclusively by ALK. PRE-PEN® (benzylpenicilloyl polylysine injection USP) is a clear, colorless, sterile solution supplied in 0.25 mL sealed glass ampules. Each ampule is sufficient to evaluate one patient by skin prick (percutaneous) test and ALK RELEASES 2020 ANNUAL REPORT ALK’s ( ALKB:DC / OMX: ALK B / AKABY / AKBLF) Board of Directors has approved the company’s 2020 annual report: ALK ended 2020 strongly, with organic growth of 16% in Q4, despite the ongoing impact of COVID. Full-year revenue and EBITDA was in line with the most recentguidance.
CONTACT US | ALK
Corporate headquarters: ALK Bøge Allé 6-8 DK-2970 Hørsholm Denmark. E-mail: reception@alk-abello.com T (+45) 4574 7576 F (+45) 4574 8690. Local offices: We have offices, production and research facilities in32 countries.
ALK PRODUCT CATALOG
ALK-Abelló A/S ∙ Bøge Allé 6 ∙ DK-2970 Hørsholm ∙ Denmark ∙ CVR no. 63717916 ∙ T +45 45 74 75 76 Privacy notice | Cookie notice | Terms of Use © 2018AFFILIATE LIST
China. ALK-Abello A/S (branch) Unit 1803, Midas Plaza, No. 1 Tai Yau Street, San Po Kong, Kowloon. Hong Kong, China. T: +852 2144 5218. F: +852 2144 5618. ALK Medical Consulting. Services Company Limited. Room 1202, Cross Region Times Building, No. 1777 North Zhongshan Road,Putuo District.
ALK - USA | A WORLD LEADER IN ALLERGY IMMUNOTHERAPY Understanding immunotherapy. Allergy immunotherapy, or AIT, treats the underlying cause of environmental allergies using a person’s own immune system. Small amounts of allergens are introduced into the body so the immune system can gradually learn to tolerate them better. It targets the specific allergy trigger that causes the immune systemVACANT POSITIONS
Auxiliar de Control BioquÃmico. 06/30/2021. Técnico para Control BioquÃmico. 06/30/2021. IT Systems Engineer – Infrastructure Services (ServiceNow) Kraków. 06/01/2021. Senior System Specialist (Senior BI Consultant) Kraków. FACHINFORMATION ZUSAMMENFASSUNG DER MERKMALE DES … 1. BEZEICHNUNG DES ARZNEIMITTELS ®GRAZAX 75.000 SQ-T - Lyophilisat zum Einnehmen 2. QUALITATIVE UND QUANTITATIVE ZUSAMMENSETZUNG Standardisierter Allergenextrakt aus Gräserpollen vomDIAGNOSTICS
A formal medical diagnosis is especially important for children as one allergy can escalate into multiple allergies, and because allergic rhinitis can lead to asthma. An early diagnosis can enable preventative treatment to begin so that the impact of any allergy can be minimised. A diagnosis is typically made based on symptoms, aphysical
WHO WE ARE | ALK
The roots of ALK can be traced back to 1923. Since then, we have been working to improve quality of life for allergy patients whose disease can severely affect their quality of life.AFFILIATE LIST
China. ALK-Abello A/S (branch) Unit 1803, Midas Plaza, No. 1 Tai Yau Street, San Po Kong, Kowloon. Hong Kong, China. T: +852 2144 5218. F: +852 2144 5618. ALK Medical Consulting. Services Company Limited. Room 1202, Cross Region Times Building, No. 1777 North Zhongshan Road,Putuo District.
NEWSROOM | ALK
Director, Global Media Relations. Corporate Communications & Investor Relations. Phone: +45 30502014. Email: Jeppe.Ilkjaer@alk.net. About ALK. Read more about the profile of ALK, the market leader in allergy immunotherapy. Logo, fonts and images. Read more about ALK’s corporate visual identity and access material for download.VACANT POSITIONS
Auxiliar de Control BioquÃmico. 06/30/2021. Técnico para Control BioquÃmico. 06/30/2021. IT Systems Engineer – Infrastructure Services (ServiceNow) Kraków. 06/01/2021. Senior System Specialist (Senior BI Consultant) Kraków.INVESTORS | ALK
Alternative link for the audiocast. Please note that audio cast takes place at 2.00pm (CEST). Participants in the conference call are kindly requested to call in before 1.55pm (CEST). Danish participants should call in on tel. +45 3544 5577 and international participants should call in on tel. +44 333 300 0804 or +1 631 913 1422.MANAGEMENT | ALK
Colleen Mansfield is the Director of Human Resources for North America at ALK-Abello Americas. As Director of Human Resources Colleen is responsible for compensation and benefits, talent management, employee relations and payroll and is based out of Port Washington, New York. LIFE SCIENCE SOLUTIONS Item# Volume Outer Diameter Quantity SEV213 2.0 cc 13 mm 100 SEV520 5.0 cc 20 mm 25 *Available in Red, Green, Blue, and Silver Caps SEV1020 10 cc 20 mm 25CONTACT US | ALK
ALK-Abello, Inc. - Main Office 1700 Royston Lane Round Rock, Texas 78664 Tel. 512.251.0037 Fax. 512.251.5882. Orders and Customers Service: 800.325.7354 ALK START SQ GRÄSERMISCHUNG UND ROGGEN 4 7. Dosierungsanleitung ALK start SQ® Gräsermischung und Roggen ermöglicht eine patientenindividuelle Behandlung. Die nachfolgend aufgelisteten Behandlungsoptionen können angewendet werden: 1. Präsaisonale Behandlung vor und bis zur Pollensaison, siehe Abschnitt7.1.
ALK - CANADA
ALK is leading the industry’s research into the role respiratory allergies play in asthma. As part of this research, we conducted the world’s largest allergy immunotherapy trial ever carried out in children to investigate the effect of a new treatment on the risk ofdeveloping asthma.
ALK | ALLERGY SOLUTIONS FOR LIFEYOUR ALLERGYOUR SOLUTIONSOUR SCIENCEOUR COMPANYSUSTAINABILITYINVESTORS Since 1923, we have consistently devised and developed major advances for the treatment of allergy. In recent years, we have invested substantially in the research and development of new, evidence-based allergy immunotherapy treatments. Read more about ALK's history. 2020 PRODUCT CATALOG 6 Call Sales Support at 800-325-7354 PRE-PEN® (benzylpenicilloyl polylysine injection USP) is manufactured by AllerQuest, LLC, and distributed exclusively by ALK. PRE-PEN® (benzylpenicilloyl polylysine injection USP) is a clear, colorless, sterile solution supplied in 0.25 mL sealed glass ampules. Each ampule is sufficient to evaluate one patient by skin prick (percutaneous) test andALK PRODUCT CATALOG
ALK-Abelló A/S ∙ Bøge Allé 6 ∙ DK-2970 Hørsholm ∙ Denmark ∙ CVR no. 63717916 ∙ T +45 45 74 75 76 Privacy notice | Cookie notice | Terms of Use © 2018 ALK RELEASES 2020 ANNUAL REPORT ALK’s ( ALKB:DC / OMX: ALK B / AKABY / AKBLF) Board of Directors has approved the company’s 2020 annual report: ALK ended 2020 strongly, with organic growth of 16% in Q4, despite the ongoing impact of COVID. Full-year revenue and EBITDA was in line with the most recentguidance.
ALK - USA | A WORLD LEADER IN ALLERGY IMMUNOTHERAPY Understanding immunotherapy. Allergy immunotherapy, or AIT, treats the underlying cause of environmental allergies using a person’s own immune system. Small amounts of allergens are introduced into the body so the immune system can gradually learn to tolerate them better. It targets the specific allergy trigger that causes the immune system LIFE SCIENCE SOLUTIONS Item# Volume Outer Diameter Quantity SEV213 2.0 cc 13 mm 100 SEV520 5.0 cc 20 mm 25 *Available in Red, Green, Blue, and Silver Caps SEV1020 10 cc 20 mm 25 ALK SOURCE MATERIALS ASM currently operates facilities in Pennsylvania, California, and Washington. This accounts for over 120,000 square feet of facilities and 800+ acres of exclusive farm land, giving ALK a tremendous amount of control over its raw materials. Learn more about ALK Source Materials facilities. Collection. These materials start as a seed anda field.
CONTACT US | ALK
ALK-Abello, Inc. - Main Office 1700 Royston Lane Round Rock, Texas 78664 Tel. 512.251.0037 Fax. 512.251.5882. Orders and Customers Service: 800.325.7354 SUBLINGUAL ALLERGY TABLETS RAGWITEK®. RAGWITEK is an allergen extract indicated as immunotherapy for the treatment of short ragweed pollen-induced allergic rhinitis with or without conjunctivitis confirmed by positive skin test or in vitro testing for pollen-specific IgE antibodies for short ragweed pollens. RAGWITEK is approved for use in adults 18 through 65 years ofage.
ALK - CANADA
ALK is leading the industry’s research into the role respiratory allergies play in asthma. As part of this research, we conducted the world’s largest allergy immunotherapy trial ever carried out in children to investigate the effect of a new treatment on the risk ofdeveloping asthma.
ALK | ALLERGY SOLUTIONS FOR LIFEYOUR ALLERGYOUR SOLUTIONSOUR SCIENCEOUR COMPANYSUSTAINABILITYINVESTORS Since 1923, we have consistently devised and developed major advances for the treatment of allergy. In recent years, we have invested substantially in the research and development of new, evidence-based allergy immunotherapy treatments. Read more about ALK's history. 2020 PRODUCT CATALOG 6 Call Sales Support at 800-325-7354 PRE-PEN® (benzylpenicilloyl polylysine injection USP) is manufactured by AllerQuest, LLC, and distributed exclusively by ALK. PRE-PEN® (benzylpenicilloyl polylysine injection USP) is a clear, colorless, sterile solution supplied in 0.25 mL sealed glass ampules. Each ampule is sufficient to evaluate one patient by skin prick (percutaneous) test andALK PRODUCT CATALOG
ALK-Abelló A/S ∙ Bøge Allé 6 ∙ DK-2970 Hørsholm ∙ Denmark ∙ CVR no. 63717916 ∙ T +45 45 74 75 76 Privacy notice | Cookie notice | Terms of Use © 2018 ALK RELEASES 2020 ANNUAL REPORT ALK’s ( ALKB:DC / OMX: ALK B / AKABY / AKBLF) Board of Directors has approved the company’s 2020 annual report: ALK ended 2020 strongly, with organic growth of 16% in Q4, despite the ongoing impact of COVID. Full-year revenue and EBITDA was in line with the most recentguidance.
ALK - USA | A WORLD LEADER IN ALLERGY IMMUNOTHERAPY Understanding immunotherapy. Allergy immunotherapy, or AIT, treats the underlying cause of environmental allergies using a person’s own immune system. Small amounts of allergens are introduced into the body so the immune system can gradually learn to tolerate them better. It targets the specific allergy trigger that causes the immune system LIFE SCIENCE SOLUTIONS Item# Volume Outer Diameter Quantity SEV213 2.0 cc 13 mm 100 SEV520 5.0 cc 20 mm 25 *Available in Red, Green, Blue, and Silver Caps SEV1020 10 cc 20 mm 25 ALK SOURCE MATERIALS ASM currently operates facilities in Pennsylvania, California, and Washington. This accounts for over 120,000 square feet of facilities and 800+ acres of exclusive farm land, giving ALK a tremendous amount of control over its raw materials. Learn more about ALK Source Materials facilities. Collection. These materials start as a seed anda field.
CONTACT US | ALK
ALK-Abello, Inc. - Main Office 1700 Royston Lane Round Rock, Texas 78664 Tel. 512.251.0037 Fax. 512.251.5882. Orders and Customers Service: 800.325.7354 SUBLINGUAL ALLERGY TABLETS RAGWITEK®. RAGWITEK is an allergen extract indicated as immunotherapy for the treatment of short ragweed pollen-induced allergic rhinitis with or without conjunctivitis confirmed by positive skin test or in vitro testing for pollen-specific IgE antibodies for short ragweed pollens. RAGWITEK is approved for use in adults 18 through 65 years ofage.
DIAGNOSTICS
A formal medical diagnosis is especially important for children as one allergy can escalate into multiple allergies, and because allergic rhinitis can lead to asthma. An early diagnosis can enable preventative treatment to begin so that the impact of any allergy can be minimised. A diagnosis is typically made based on symptoms, aphysical
2020 PRODUCT CATALOG 6 Call Sales Support at 800-325-7354 PRE-PEN® (benzylpenicilloyl polylysine injection USP) is manufactured by AllerQuest, LLC, and distributed exclusively by ALK. PRE-PEN® (benzylpenicilloyl polylysine injection USP) is a clear, colorless, sterile solution supplied in 0.25 mL sealed glass ampules. Each ampule is sufficient to evaluate one patient by skin prick (percutaneous) test andWHAT WE DO | ALK
ALK is a global pharmaceutical company focusing on allergy treatment, prevention and diagnosis. We are devoted to being there for people with allergies by developing pharmaceutical products that target the actual cause of allergy.WHO WE ARE | ALK
The roots of ALK can be traced back to 1923. Since then, we have been working to improve quality of life for allergy patients whose disease can severely affect their quality of life.ALLERGY VACCINES
Allergy immunotherapy (AIT) treatments are classified as biologics, because they are produced from living cells rather than being synthesised by chemists. ALK’s AIT products are derived from natural allergen sources such as grass pollen, tree pollen and house dust mites. They come in three different forms: Injections.GLOBAL PRESENCE
Addressing a global problem. ALK is present in 41 countries in the world and around 1.9 million people worldwide are using our products. It is estimated that 10-20% of allergic rhinitis sufferers have a condition which is not well controlled despite the use of symptom-relieving medication. ALK's products can potentially benefitthese patients.
ALLERGY IMMUNOTHERAPY Several kinds of over the counter medications may relieve your allergic symptoms, such as pills or sprays. Another kind of treatment is immunotherapy, allergySEARCH | ALK
Contact Us ALK-Abello, Inc. - Main Office 1700 Royston Lane Round Rock, Texas 78664 Tel. 512.251.0037 Fax. 512.251.5882 Orders and Customers Service: 800.325.7354OUR HISTORY
Indications. GRASTEK®, RAGWITEK®, and ODACTRA® are allergen extracts indicated as immunotherapy for the treatment of grass (GRASTEK), ragweed pollen-induced (RAGWITEK), and house dust mite (HDM)-induced allergic rhinitis, with or without conjunctivitis, confirmed by positive skin test or in vitro testing for pollen-specific IgE antibodies for Timothy grass or cross-reactivegrass pollens
MANAGEMENT | ALK
Colleen Mansfield is the Director of Human Resources for North America at ALK-Abello Americas. As Director of Human Resources Colleen is responsible for compensation and benefits, talent management, employee relations and payroll and is based out of Port Washington, New York. powered by: Cookie Information THIS WEBSITE USES COOKIES We use cookies on this site to enhance your user experience. By clicking any link on this page you agree to our privacy policyand give us
your consent to set cookies. About cookies Use necessary cookies only Update consent Accept all Show details Hide detailsSTRICTLY NECESSARY
Strictly necessary cookies help make a website navigable by activating basic functions such as page navigation and access to secure website areas. Without these cookies, the website would not be able to workproperly.
Data Processor: PHP
Purpose: Required for the website to perform properly. Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: Session
Name: PHPSESSID
Provider: login.doccheck.com Data Processor: Drupal Purpose: Supports the functions of a "Content Management System" to ensure that the website works properly. Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: Session
Name: has_js
Provider: www.alk.net Data Processor: Amazon Web Services Purpose: Required for the website to perform properly. Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: 7 days
Name: AWSALB
Provider: alkabello.easycruit.com Data Processor: New Relic Purpose: Collects information about the website and its contents for reporting and security purposes. Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: Session
Name: JSESSIONID
Provider: .nr-data.net Data Processor: Cookie Information Purpose: Supports the website's technical functions. Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: a year
Name: CookieInformationConsent Provider: www.alk.net Data Processor: Amazon Web Services Purpose: Supports the website's technical functions. Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: 7 days
Name: AWSALBCORS
Provider: alkabello.easycruit.com Data Processor: Microsoft, ASP.NET Purpose: Supports the integration of a third-party platform on thewebsite.
Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: Session
Name: ASP.NET_SessionId Provider: tools.euroland.com Data Processor: Drupal Purpose: Supports the functions of a "Content Management System" to ensure that the website works properly. Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: Session
Name: DrupalVisitorMobile Provider: ir.alk.netFUNCTIONAL
Functional cookies make it possible to save information that changes the way the website appears or acts. For instance your preferredlanguage or region.
Data Processor: Visma, Easycruit Purpose: Enables the recruitment function on the website. Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: a year
Name: __atuvc
Provider: alkabello.easycruit.com Data Processor: Visma, Easycruit Purpose: Enables the recruitment function on the website. Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: 30 minutes
Name: __atuvs
Provider: alkabello.easycruit.com Data Processor: Google Purpose: Ensures the website and application security. Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: 6 months
Name: _GRECAPTCHA
Provider: .google.comSTATISTICAL
Statistical cookies help the website owner understand how visitors interact with the website by collecting and reporting information. Data Processor: Google Analytics Purpose: Collects information about the users and their activity on the website for analytics and reporting purposes. Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: 2 years
Name: _ga
Provider: .alk.net
Data Processor: Google Analytics Purpose: Collects information about the users and their activity on the website for analytics and reporting purposes. Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: a day
Name: _gid
Provider: .alk.net
Data Processor: Sleeknote Purpose: Collects information about the users and their activity on the website. The information is used to track and analyze user behavior and to meet individual user needs. Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: Session
Name: SNS
Provider: www.alk.net Data Processor: Google Analytics Purpose: Collects information about the users and their activity on the website for analytics and reporting purposes. Data Processor Privacy Policy: Data Processor Privacy Policy Expiry: a few seconds Name: _gat_UA-xxx-xxxProvider: .alk.net
Data Processor: Google Analytics Purpose: Collects information about the users and their activity on the website for analytics and reporting purposes. Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: a minute
Name: _gat
Provider: .alk.net
Data Processor: Google Analytics Purpose: Collects information about the users and their activity on the website for analytics and reporting purposes. Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: 6 months
Name: __utmz
Provider: .ir.alk.net Data Processor: Google Analytics Purpose: Collects information about the users and their activity on the website for analytics and reporting purposes. Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: 30 minutes
Name: __utmb
Provider: .ir.alk.net Data Processor: Google Analytics Purpose: Collects information about the users and their activity on the website for analytics and reporting purposes. Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: 2 years
Name: __utma
Provider: .ir.alk.net Data Processor: Google Analytics Purpose: Collects information about the users and their activity on the website for analytics and reporting purposes. Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: Session
Name: __utmc
Provider: .ir.alk.net Data Processor: Google Analytics Purpose: Collects information about the users and their activity on the website for analytics and reporting purposes. Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: 10 minutes
Name: __utmt
Provider: .ir.alk.netMARKETING
Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and interesting to the individual user and thus more valuable for publishers and third-partyadvertisers.
Data Processor: LinkedIn Purpose: Supports online marketing by collecting information about the users to promote products through partners and other platforms. Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: a month
Name: UserMatchHistory Provider: .linkedin.com Data Processor: LinkedIn Purpose: Supports online marketing by collecting information about the users to promote products through partners and other platforms. Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: 2 years
Name: bcookie
Provider: .linkedin.com Data Processor: Youtube, Google Purpose: Collects information about the users and their activity on the website through embedded video players with the purpose of delivering targeted advertising. Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: 17 years
Name: CONSENT
Provider: .youtube.com Data Processor: Sleeknote Purpose: Collects information about the users, which is used for market analytics and reporting purposes. Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: a year
Name: _sn_m
Provider: www.alk.net Data Processor: AddThis Purpose: Used for online marketing by collecting information about the users and their activity on the website. The information is used to target advertising to the users across the web. Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: a year
Name: uvc
Provider: .addthis.com Data Processor: Youtube, Google Purpose: Collects information about the users and their activity on the website through embedded video players with the purpose of delivering targeted advertising. Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: Session
Name: YSC
Provider: .youtube.com Data Processor: Youtube, Google Purpose: Collects information about the users and their activity on the website through embedded video players with the purpose of delivering targeted advertising. Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: 6 months
Name: VISITOR_INFO1_LIVE Provider: .youtube.com Data Processor: LinkedIn Purpose: Supports online marketing by collecting information about the users to promote products through partners and other platforms. Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: 2 years
Name: bscookie
Provider: .www.linkedin.com Data Processor: AddThis Purpose: Used for online marketing by collecting information about the users and their activity on the website. The information is used to target advertising to the users across the web. Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: a year
Name: xtc
Provider: .addthis.com Data Processor: LinkedIn Purpose: Collects information about the users and their activity on the website. The Information is used to track and analyze user behavior, to meet the individual user needs and to deliver targetedadvertising.
Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: a month
Name: AnalyticsSyncHistory Provider: .linkedin.com Data Processor: LinkedIn Purpose: Supports online marketing by collecting information about the users to promote products through partners and other platforms. Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: a day
Name: lidc
Provider: .linkedin.com Data Processor: Doubleclick, Google Purpose: Used for online marketing by collecting information about the users and their activity on the website. The information is used to target advertising to the user across different channels anddevices.
Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: a year
Name: IDE
Provider: .doubleclick.net Data Processor: AddThis Purpose: Used for online marketing by collecting information about the users and their activity on the website. The information is used to target advertising to the users across the web. Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: a year
Name: loc
Provider: .addthis.com Data Processor: LinkedIn Purpose: Supports online marketing by collecting information about the users to promote products through partners and other platforms. Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: Session
Name: lang
Provider: .ads.linkedin.com Data Processor: LinkedIn Purpose: Supports online marketing by collecting information about the users to promote products through partners and other platforms. Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: Session
Name: lang
Provider: .linkedin.com Data Processor: Sleeknote Purpose: Collects information about the users, which is used for market analytics and reporting purposes. Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: a year
Name: _sn_a
Provider: www.alk.net Data Processor: Sleeknote Purpose: Collects information about the users, which is used for market analytics and reporting purposes. Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: a year
Name: _sn_n
Provider: www.alk.net Data Processor: Adobe Experience Cloud Purpose: Collects information about the users and their activity on the website. The information is used to track and analyze user behaviour and to deliver targeted advertising. Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: Session
Name: AMCVS_xxx
Provider: .alk.net
Data Processor: Adobe Experience Cloud Purpose: Supports the integration of a third-party platform on the website to deliver targeted advertising. Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: 6 months
Name: demdex
Provider: .demdex.net Data Processor: LinkedIn Purpose: Supports online marketing by collecting information about the users to promote products through partners and other platforms. Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: 2 years
Name: li_gc
Provider: .linkedin.com Data Processor: ShareThis Purpose: Collects information about the users and their activity on the website. The information is used to track and analyze user behaviour and to deliver targeted advertising. Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: Session
Name: __sharethis_cookie_test__ Provider: ir.alk.net Data Processor: Adobe Experience Cloud Purpose: Supports the integration of a third-party platform on the website to deliver targeted advertising. Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: 2 years
Name: AMCV_*%40AdobeOrgProvider: .alk.net
Data Processor: Adobe Experience Cloud Purpose: Collects information about the users and their activity on the website. The Information is used to track and analyze user behavior, to meet the individual user needs and to deliver targetedadvertising.
Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: a year
Name: everest_g_v2
Provider: .everesttech.net Data Processor: Adobe Experience Cloud Purpose: Collects information about the users and their activity on the website. The Information is used to track and analyze user behavior, to meet the individual user needs and to deliver targetedadvertising.
Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: Session
Name: everest_session_v2 Provider: .everesttech.net Data Processor: Adobe Experience Cloud Purpose: Supports the integration of a third-party platform on the website to deliver targeted advertising. Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: 6 months
Name: dpm
Provider: .dpm.demdex.net Data Processor: Adobe Experience Cloud Purpose: This cookie is set and read by the JavaScript code to determine if cookies are enabled. Data Processor Privacy Policy: Data Processor Privacy PolicyExpiry: Session
Name: s_cc
Provider: .alk.net
UNCLASSIFIED
We are in the process of classifying unclassified cookies together with the providers of the individual cookies. No cookies in this categoryStrictly necessary
Functional
Statistical
Marketing
powered by: Cookie InformationCOOKIE DECLARATION
Your consent applies to the following domains: alk.net, ir.alk.net, ir.dk.alk.net Cookie declaration last updated on 20.05.2021 Cookie category consent settings Accept all THIS WEBSITE IS OWNED AND OPERATED BYALK
Bøge Allé 1 6-8
DK-2970 Hørsholm
CVR: 63717916
E-mail: reception@alk-abello.com Phone: +45 4574 7576WHAT IS A COOKIE?
A cookie is a small text file. It does not contain any personal information and is not able to collect information. Two types of cookies can be used, "session-only" and "persistent". "Session-only" cookies are deleted when you end your browser session. "Persistent cookies" remain on your device for the time period set in the cookie after which time they delete themselves. However, these cookies may be renewed every time you visit the website.COOKIE TYPES
It is common to distinguish between first-party cookies and-third party cookies. First-party cookies are allocated to the website that you visit while third-party cookies come from a third-party, such as a web analytics program. WHY DO WE USE COOKIES? We use cookies to assess content usage and to compile statistics about the use of the website in order to improve the user experience. This data may be used to define where the visitors come from, what content is viewed and for how long. This information cannot be used to identify a visitor as an individual. Both first-party and third-party cookies may be used on this website. HOW LONG WILL COOKIES BE STORED ON MY COMPUTER? Cookie lifetime may vary. Some cookies will disappear when you close the browser while others exist for longer. For more information on cookie expiry see the cookie declaration. CAN I STILL VISIT THE WEBSITE IF THE COOKIE-FUNCTION IS DISABLED? Yes. Should you have cookies disabled on your online device, you will continue to have the same access to the website content as with cookies enabled. However, some functions such as surveys and tools might operate with reduced functionality or not at all. HOW TO AVOID OR DELETE A COOKIE? Most browsers accept cookies by default. You can alter your browser settings to not accept cookies or delete the cookies from your computer. Different web browsers may use different methods for managing cookies. Please follow the instructions below, from the most common web browser manufacturers directly, to configure your browsersettings*.
Microsoft Internet Explorer (IE)Google Chrome
Safari
Firefox
* These links are to third party sites, over which we have no control – no liability can be claimed if they are inaccurate. The cookie declaration is updated monthly by Cookie Information . If you have any questions please write to info@cookieinformation.dk.* Your allergy
* What is allergy
* House dust mite allergy* Pollen allergy
* Living with allergy * Socio-economic impact * What is allergic asthma * How is allergy diagnosed* Treating allergy
* Our solutions
* Consumer healthcare* Diagnostics
* Allergy vaccines
* Production
* Emergency medicine* Our science
* Allergy immunotherapy * Healthcare Professionals* Reweal
* Webinars
* Pipeline
* Clinical trials
* Clinical data sharing* Our company
* Newsroom
* Stories
* Privacy
* Global presence
* Organisation
* History
* Owners
* Sustainability
* Investors
* Overview
* Financial reporting* Risk management
* Reporting standards* Auditors
* Governance
* IR policy
* Management
* Board of directors * Annual general meeting * Annual general meeting (DK)* News & Events
* Company releases
* Company releases (DK) * Webcasts & presentations* Investor calendar
* The Share
* Dividend history
* Analyst coverage
* Analyst estimates
* Shareholder information* Authorizations
* ADR Programme
* Contact IR
* Management
* Board of directors* AGM
* AGM (DK)
* Careers
* Working at ALK
* Vacant positions
* Cultural Beliefs
* Select country
Fulltext search
Search
ALK
ALLERGY SOLUTIONS FOR LIFE Read about ALK's allergy solutionsTAKE BACK CONTROL
More than 500 million people worldwide have allergies. Many of them suffer in silence because the way ahead is too confusing.Watch the video
NEWS
See all
*
Post date
03/10/2021
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staffRead more
*
Post date
03/03/2021
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staffRead more
*
Post date
03/02/2021
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staffRead more
*
Post date
05/10/2021
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staffRead more
*
Post date
05/05/2021
Three-month interim report (Q1) 2021Read more
*
Post date
04/28/2021
Release date of three-month interim report (Q1) 2021 for ALK andaudio cast
Read more
*
Post date
04/19/2021
ALK gains paediatric approval for its ragweed SLIT-tablet in the USARead more
*
Post date
03/26/2021
Grant of share options and performance shares to members of the Board of Management and key employeesRead more
*
Post date
03/18/2021
Annual General Meeting in ALK-Abelló A/S held on 18 March 2021Read more
*
Post date
03/10/2021
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staffRead more
*
Post date
03/03/2021
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staffRead more
*
Post date
03/02/2021
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staffRead more
*
Post date
05/10/2021
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staffRead more
*
Post date
05/05/2021
Three-month interim report (Q1) 2021Read more
*
Post date
04/28/2021
Release date of three-month interim report (Q1) 2021 for ALK andaudio cast
Read more
PrevNext
1
2
3
4
5
ALK SUPPORTS ESOSA 2021 The SOSA programme includes the most recent updates in the field of specific allergy. The scientific programme for SOSA is developed by a pre-eminent International Scientific Committee and involves a faculty of around 35 distinguished speakers from the allergy scientific community. In 2021, to adapt to the COVID-19 limitations, SOSA will be held as a virtual event: eSOSA 2021.Register here
Strategy update: Focus areas during 2021-23 Having made the necessary, significant investments to transform ALK, we are now entering the next phase of the company’s development, where we must carefully work to sustain long-term growth, while also returning ALK to profitability. Read more about ALK's strategy update ALK rewards excellence in allergy The Henning Løwenstein Research Award is a biennial award given to a young scientist who has shown excellence within the field of allergy.How to apply
PrevNext
1
2
SEASONAL ALLERGY SYMPTOMS CAN BE CONFUSED WITH COVID-19 Therefore allergy symptoms should be kept under the best possible control. Watch Dr Glenis Scadding's expert advise in respect of seasonal allergies and COVID-19. For further information visit EUFOREA SEASONAL_ALLERGIC_RHINITIS_IN_RELATION_TO_COVID-19 Video of seasonal_allergic_rhinitis_in_relation_to_covid-19ALK IN BRIEF
Allergy at a glance
Allergic rhinitis - popularly known as hay fever - is a widespread chronic disease. It is estimated to affect one in four persons in the industrialised world. Read more about allergy and its symptomsOur solutions
By collecting information and the latest and most trusted solutions together in one place, we want to make allergy surprisingly simple tomanage.
Read more about ALK's allergy solutionsOur heritage
Since 1923, we have consistently devised and developed major advances for the treatment of allergy. In recent years, we have invested substantially in the research and development of new, evidence-based allergy immunotherapy treatments. Read more about ALK's historyOur responsibility
We aim to operate in a sustainable and ethical manner across our business and we underpin these aims with a range of policies andcommitments.
Read more about sustainability FacebookTwitter LinkedIn
SELECT COUNTRY MENU
* Change Country
QUICK LINKS
* Contact us
* News
* Media
* Vacant jobs
* Products
ALK FOOTER COPYRIGHT TEXT ALK-Abelló A/S ∙ Bøge Allé 6-8 (Visiting Address: Bøge Allé 1) ∙ DK-2970 Hørsholm ∙ Denmark ∙ CVR no. 63717916 ∙ T +45 45 74 75 76 PRIVACY NOTICE| COOKIE
NOTICE |
LEGAL DISCLAIMER
© 2018 ALK ∙ All rights reserved✓
Thanks for sharing!
AddToAny
More…
Details
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0